Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.

Li B. et al, (2022), Nature communications, 13

Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics.

Dyson L. et al, (2021), Nature communications, 12

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.

Wei J. et al, (2021), Nature microbiology

OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.

Hinch R. et al, (2021), PLoS computational biology, 17

Challenges in control of COVID-19: short doubling time and long delay to effect of interventions.

Pellis L. et al, (2021), Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 376

Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics

Dyson L. et al, (2021)

USING PHYLOGENETICS TO ACCURATELY INFER HIV-1 TRANSMISSION DIRECTION

Villabona-Arenas CJ. et al, (2021)

SARS-CoV-2 within-host diversity and transmission.

Lythgoe KA. et al, (2021), Science (New York, N.Y.)

Time to evaluate COVID-19 contact-tracing apps.

Colizza V. et al, (2021), Nat Med, 27, 361 - 362

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa

Downs L. et al, (2020)

Estimating hepatitis B virus cccDNA persistence in chronic infection

LYTHGOE K. et al, (2020), Virus Evolution

Coronavirus: full peer review in hours.

Sutherland WJ. and Lythgoe KA., (2020), Nature, 584

Number of HIV-1 founder variants is determined by the recency of the source partner infection

Villabona-Arenas CJ. et al, (2020), Science

Number of HIV-1 founder variants is determined by the recency of the source partner infection.

Villabona-Arenas CJ. et al, (2020), Science (New York, N.Y.), 369, 103 - 108

Number of HIV-1 founder variants is determined by the recency of the source partner infection

Villabona-Arenas CJ. et al, (2020), Science

A de novo approach to inferring within-host fitness effects during untreated HIV-1 infection.

Illingworth CJR. et al, (2020), PLoS pathogens, 16

Correction to: CpG‑creating mutations are costly in many human viruses (Evolutionary Ecology, (2020), 34, 3, (339-359), 10.1007/s10682-020-10039-z)

Caudill VR. et al, (2020), Evolutionary Ecology, 34, 361 - 362

Within-host genomics of SARS-CoV-2

Lythgoe K. et al, (2020)

Challenges in control of COVID-19: short doubling times and long delay to effect of interventions

Pellis L. et al, (2020)

Limited evolution despite years of measurable viremia in a cART-treated seronegative HIV-1 positive individual

Fryer H. et al, (2020)

Load More

Include forthcoming?